The Perception and Perspectives of Researchers by Indian Zones

Authors

  • Vishal Vennu School of Pharmacy, Lingaya’s Vidyapeeth, Faridabad, India and Department of Rehabilitation Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.

DOI:

https://doi.org/10.9734/bpi/mono/978-93-91882-02-0/CH9

Keywords:

Perception, perspectives, zone, researcher, clinical trial, governmental rules, ethic committee

Abstract

No research evaluated the perception and perspectives of researchers from different Indian zones on India's new drugs and clinical trial rules of 2019 (NDCTR-19). The current study aimed to approach this passage. The results advance the goal of the new rules that help speed up trials and extend the pharma industry in the country. An extensive study at the national level, including all six zones, is needed to generalize researchers' beliefs on the topic.

Published

2021-08-30

How to Cite

Vishal Vennu. (2021). The Perception and Perspectives of Researchers by Indian Zones. India’s New Drugs and Clinical Trial Rules: Perception and Perspectives of Indian Researchers, 47–53. https://doi.org/10.9734/bpi/mono/978-93-91882-02-0/CH9

Issue

India’s New Drugs and Clinical Trial Rules: Perception and Perspectives of Indian Researchers

Section

Contents